ARCHIVES

NCI CTEP Approved Trials For the Month of September

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

In Brief: XIIIth Congress Draws Record Number Of Abstracts, 3,000 Registrants So Far; Exhibit Area Sold Out

March 5, 1982

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011